FR2826581B1 - Utilisation du tripeptide lys-pro-val (kpv) dans le traitement des melanomes - Google Patents

Utilisation du tripeptide lys-pro-val (kpv) dans le traitement des melanomes

Info

Publication number
FR2826581B1
FR2826581B1 FR0108680A FR0108680A FR2826581B1 FR 2826581 B1 FR2826581 B1 FR 2826581B1 FR 0108680 A FR0108680 A FR 0108680A FR 0108680 A FR0108680 A FR 0108680A FR 2826581 B1 FR2826581 B1 FR 2826581B1
Authority
FR
France
Prior art keywords
kpv
melanomas
lys
pro
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0108680A
Other languages
English (en)
Other versions
FR2826581A1 (fr
Inventor
Yann Mahe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0108680A priority Critical patent/FR2826581B1/fr
Publication of FR2826581A1 publication Critical patent/FR2826581A1/fr
Application granted granted Critical
Publication of FR2826581B1 publication Critical patent/FR2826581B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
FR0108680A 2001-06-29 2001-06-29 Utilisation du tripeptide lys-pro-val (kpv) dans le traitement des melanomes Expired - Fee Related FR2826581B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0108680A FR2826581B1 (fr) 2001-06-29 2001-06-29 Utilisation du tripeptide lys-pro-val (kpv) dans le traitement des melanomes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0108680A FR2826581B1 (fr) 2001-06-29 2001-06-29 Utilisation du tripeptide lys-pro-val (kpv) dans le traitement des melanomes

Publications (2)

Publication Number Publication Date
FR2826581A1 FR2826581A1 (fr) 2003-01-03
FR2826581B1 true FR2826581B1 (fr) 2005-10-07

Family

ID=8864974

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0108680A Expired - Fee Related FR2826581B1 (fr) 2001-06-29 2001-06-29 Utilisation du tripeptide lys-pro-val (kpv) dans le traitement des melanomes

Country Status (1)

Country Link
FR (1) FR2826581B1 (fr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1323839C (fr) * 1987-05-11 1993-11-02 Loren Ralph Pickart Methodes pour stimuler la pousse des poils
EP0389950A1 (fr) * 1989-03-23 1990-10-03 Lion Corporation Inhibiteur de l'hormone stimulant les mélanocytes et préparation à usage externe la contenant
CA2139127A1 (fr) * 1992-06-25 1994-01-06 Chiron Corporation Compositions permettant d'inhiber la formation d'hormones proteiques et leur utilisation
GB9401689D0 (en) * 1994-01-28 1994-03-23 Univ Manchester Diagnosis and treatment of endocarditis
FR2733421B1 (fr) * 1995-04-28 1997-06-06 Oreal Utilisation de derives de l'hormone stimulatrice des melanocytes de type alpha pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
FR2738746B1 (fr) * 1995-09-19 1997-11-14 Oreal Utilisation d'au moins un peptide dans une composition cosmetique ou pour la preparation d'un medicament
SE9801571D0 (sv) * 1998-05-05 1998-05-05 Wapharm Ab Melanokortin-1-receptorselektiva föreningar
ES2286876T3 (es) * 1999-10-04 2007-12-01 L'oreal Uso de un peptido que previene las reacciones de ijntolerancia de la piel, en particular en composiciones cosmeticas.

Also Published As

Publication number Publication date
FR2826581A1 (fr) 2003-01-03

Similar Documents

Publication Publication Date Title
FR15C0030I2 (fr) Composes d'acide benzoique 1,2,4-oxadiazole et utilisation de ceux-ci dans la suppression non-sens et le traitement de maladies
ATE345136T1 (de) Cysteinprotease-hemmer mit 2-cyano-4-amino- pyrimidinstruktur und cathepsin-k-hemmender wirkung zur behandlung von entzündungen und anderen erkrankungen
MA27381A1 (fr) Association synergique d'un ligand de alpha-2-delta et d'un inhibiteur de pdev pour une utilisation dans le traitement de la douleur
DK1487541T3 (da) Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelse af perifere vaskulære sygdomme
DE50214540D1 (de) Stanz bei der behandlung von wunden
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
EP1767197A3 (fr) Trategies therapeutiques pour la prevention et le traitement de la maladie d'alzheimer
EE200300485A (et) Tiohüdantoinid ja nende kasutamine diabeedi raviks
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
FR2809005B1 (fr) Utilisation du manganese dans le traitement des rides
NO20055820D0 (no) Peptider til anvendelse ved behandling av overvekt
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
NO20033123D0 (no) Terapeutisk hinnedannende sammensetning og behandlingsplan derav
FR2812197B1 (fr) Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
DK1458399T3 (da) Pregnansteroider til brug i behandlingen af CNS-sygdomme
NO20070892L (no) Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.
EP1581243A4 (fr) Lactoferrine orale pour le traitement des sepsies
AU2002346594A1 (en) Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation
IS7417A (is) Ambroxól til að meðhöndla kvalafullt ástand í munni og koki
AU2003206945A8 (en) Use of proteinase inhibitors in the treatment of autoimmune diseases
FR2826581B1 (fr) Utilisation du tripeptide lys-pro-val (kpv) dans le traitement des melanomes
AU2003239184A8 (en) Treatment and inhibition of ocular infections and wounds by cap37 and cap37 peptides
DK1461042T3 (da) Anvendelse af desoxypeganin til behandling af klinisk depression
DE50209171D1 (de) Verhinderung von membranverblockung bei der abwasseraufbereitung bei der phosphatierung

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20090228